[Bone XXXX and atraumatic necrosis of the femoral head : Therapy].

@entity66 @entity625 @entity63 @entity5 @entity171 @entity79 @entity6866 @entity158 @entity236 @entity2530
BACKGROUND: An increase in interstitial bony fluid occurs in bone- @entity236 (BME). The exact pathogenetic processes still remain unknown. BME is an unspecific finding that can occur on its own or accompany @entity66 and pathologies. GOAL: Literature review and presentation of new guidelines. MATERIAL AND METHODS: This is a narrative literature review followed by current advice for the therapy of atraumatic @entity2530 of the hip, based on the recently published S3-guidelines for this disease. RESULTS AND DISCUSSION: The differentiation of at least 3 different etiologies is proposed (mechanic, reactive and @entity63 ). Difficult, but important, is the distinction between the mostly painful, but benign entities ( @entity236 , @entity79 ) and the progressive pathologies ( @entity2530 , @entity625 , @entity6866 , @entity5 ). Treatment options are dependent on etiology and clinic and can often be symptomatic. Core decompression is the surgical gold standard, leading to immediate pressure relief and therefore reduction in @entity158 . Recently, it was shown that intravenous administration of Iloprost and @entity171 are also effective in achieving a reduction of BME and @entity158 , with considerable improvement in the accompanying symptoms. The combination of core decompression and infusion seems to be another possible optimization ofthe therapy, in particular in the treatment of @entity2530 .
